37.27.138    INTENSIVE OUTPATIENT TREATMENT COMPONENT REQUIREMENT

(1) Individuals needing withdrawal management, inpatient, or residential services must be referred to an appropriate treatment program.

(2) Individuals manifesting signs and symptoms of a condition that warrants acute medical care must be referred to a hospital.

(3) Intensive outpatient services must include referral, transfer, discharge, aftercare, and follow-up services that ensure a continuity of care.

(4) The program must provide availability of professional counseling services 24 hours per day, 7 days per week.

(5) The program must develop policies, procedures, and plans to address the above-listed requirements.

(6) Program effectiveness and quality assurance must:

(a) be designed to ensure that the care provided to individuals is evaluated and updated every month, according to the needs of each individual.

(b) be accomplished through reviews, which all involved treatment staff attend.

(7) Effectiveness review is a process to evaluate the allocated services and resources to ensure the program′s services are necessary, cost efficient, and effectively utilized. Effectiveness reviews must:

(a) be designed to achieve cost efficiency, increase effective utilization of program′s services, and verify the necessity of services provided;

(b) address under-utilization, over-utilization, and inefficient scheduling of the program′s resources.

(c) ensure methods for identifying and monitoring utilization and effectiveness related problems including analysis of the appropriateness and necessity of admission, caseload, continued stays, recidivism, completion ratios, frequency of services, and delays in the provision of services, effectiveness of the aftercare plan based on verification of referrals and results of follow-up, as well as utilization of the findings of related quality assurance activities and all current relevant documentation.

 

History: 53-24-208, MCA; IMP, 53-24-208, MCA; NEW, 1992 MAR p. 1477, Eff. 7/17/92; TRANS, from DOC, 1998 MAR p. 1502; AMD, 2018 MAR p. 725, Eff. 5/1/18.